期刊文献+

FADD在帕金森病大鼠的表达及临床意义 被引量:1

Expression of FADD in PD rats and its clinical significinces
下载PDF
导出
摘要 目的研究FADD(Fas死亡结构域蛋白)在帕金森病大鼠模型中的表达,并探讨PD与死亡受体凋亡通路的关系。方法用免疫组化(THC)法检测30例健康雄性大鼠,随机分对照组6只和模型组24只。检测FADD的表达情况。结果帕金森病模型大鼠FADD表达上调,分别与对照组比较,组间差异有显著性(P<0.01),结论FADD表达异常在帕金森发病机制起着重要的作用,从而推断FADD介导的凋亡通路与帕金森病的关系。 Objective: To study the expression of FADD in the PD rats, and explore the relationship betwween PD and apoptosis. Method: Immunohistochemistry methed hibrization were used to detect the expression of FADD in30 rats who were individe into control(6 rats)groups and experlmental[ 24 rats ] groups. Result:the expression of FADD in PD rats is active comparing the control groups. All the defference are significant statistically in groups (P 〈0. 01 ). Conclusion :the incrrect expression of FADD is important to parkinson and conclude the relation of the FADDand parkinson.
出处 《泰山医学院学报》 CAS 2007年第2期116-119,共4页 Journal of Taishan Medical College
关键词 FADD 帕金森病 凋亡 FAS FADD parkinson apoptosis Fas
  • 相关文献

参考文献12

  • 1Schapira AH.Pathogenesis of Parkinson'disease[J].Baillieres Clin Neurol,1997;6:15-36.
  • 2张旺明,徐如祥,蔡颖谦,张世忠.6-羟多巴胺诱导帕金森病模型鼠黑质神经细胞凋亡的观察[J].中华老年医学杂志,2000,19(2):119-121. 被引量:13
  • 3刘军,肖颂华,周道友,刘中霖,陶恩祥,邢诒刚.6-羟多巴胺诱致大鼠早期黑质多巴胺能神经元凋亡的实验研究[J].中华老年医学杂志,2003,22(11):681-683. 被引量:15
  • 4Chinnaiyan A M,Rourke K,Te wari M,et al.FADD,a novel death do main-containing protein,interacts with the death domain of Fas and initiates apoptosis[J].Cell,1995,81(4):505-512.
  • 5Boldin M P,Mett I L,Varfolomeev E E,et al.Self-assoication of the "death domain" of the p55 tumour necrosis factor (TNF) receptor and Fas /APO1 promopts signaling for TNF and Fas/Apol effects[J].J.Biol Che m,1995,270(1):387-391.
  • 6Zhang JK,Lado D,Chen A,et al.Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking[J].FADD/MORT1 Nature,1998,392;2965.
  • 7Choi WS,Yoon SY,Oh TH,et al.Two distinct mechanis ms are involved in 6-hydroxydopamine and MPTP induced dopaminergic neuronal cell death:role of caspases[J].J Neurosci Res,1999,57:86-87.
  • 8Tatton NA,Kish SJ.In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labeling and acridine orange staning[J].Neuroscience,1997,77(4):1037.
  • 9Tompkins MM,Bagall EJ,Zamrini E,et al.Am J Pathal,1997,150(1):119-131.
  • 10Kingsbury AE,Mardsen CD,Foster OJ.Mov-Disord,1998,13(6):877-884.

二级参考文献10

  • 1张开.TUNEL法──细胞凋亡的组织化学鉴定法[J].日本医学介绍,1995,16(10):469-469. 被引量:11
  • 2朱道立.震颤性麻痹动物模型的研究[J].上海实验动物科学,1995,15(1):2-5. 被引量:1
  • 32,MacayaA.Apoptosisinthenervoussystem.RevNeurol,1996,24:1356-1360.
  • 43,Savitz SI, Rosenbaum DM. Aopoptosis in neurological diseases.Neurosurg,1998,42:555-572.
  • 54,Anglade P, Vyas S, Javoy F, et al. Apoptosis degeneration of nigral dopaminergicneurons in Parkinson's disease.Soc Neurosci Abstr,1995, 21:1250.
  • 65,Mochizuki H,Goto K,Mori H,et al.Histochemical detection of apoptosis in Parkinson'sdisease.J Neurol Sci,1996,137:120-123.
  • 76,Tompkins MM,Basgall EJ,Zamrini E,et al.Apoptotic-like changes in Lewy-body-associateddisorders and normal aging in subtantia nigral neurons. Am J Pathol, 1997,150:119-131.
  • 8Siegfried K?sel,Rupert Egensperger,Ulrich von Eitzen,Parviz Mehraein,M. B. Graeber. On the question of apoptosis in the parkinsonian substantia nigra[J] 1997,Acta Neuropathologica(2):105~108
  • 9M. Gerlach,P. Riederer. Animal models of Parkinson’s disease: An empirical comparison with the phenomenology of the disease in man[J] 1996,Journal of Neural Transmission(8-9):987~1041
  • 10周国庆,周考达,李宁丽,沈佰华.6羟多巴胺诱导PC12细胞凋亡的研究[J].脑与神经疾病杂志,1997,5(5):269-271. 被引量:5

共引文献25

同被引文献18

  • 1李颖,包晓群,李静.针对Fas基因RNA抑制作用前后帕金森病细胞相关因子变化的凋亡作用[J].中国实验诊断学,2006,10(9):963-964. 被引量:1
  • 2谢安木,薛莉,刘焯霖.Synphilin-1寡核苷酸对帕金森病酪氨酸羟化酶表达的影响[J].青岛大学医学院学报,2007,43(3):199-201. 被引量:6
  • 3Fasano M, Lopiano L.Alpha-synuclein and Parkinson's disease: aproteomic view[J]. Expert Rev Proteomics,2008,5:239-248.
  • 4Kim PK, Wang Y, Gambotto A, et al. Hepatocyte Fas-associating death domain protein/mediator of receptor-induced toxicity (FADD/MORT1) levels increase in response to pro-apoptotic stimuli[J]. J Biol Chem,2002,277:38855-38862.
  • 5Vermes I, Steur EN, Reutelingsperger C, et al. Decreased concentration of annexin V in Parkinsonian cerebrospinal fluid:speculation on the underlying cause [J].Mov Disord,1999,14:1008-1010.
  • 6Hartman A, Hunot S, Michel PP, et al. Caspase-23:A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease[J]. Proc Natl Acad Sci U S A,2000,97:2875-2880.
  • 7Lee WC, Berry R, Hohenstein P, et al. SiRNA as a tool for investigating organogenesis:The pitfalls and the promises[J]. Organogenesis,2008,4:176-181.
  • 8Peters M, Bletsch M, Catapano R, et al. RNA interference in hippocampus demonstrates opposing roles for CREB and PPlalpha in contextual and temporal long-term memory[J]. Genes Brain Behav,2009,8:320-329.
  • 9Ralph GS, Radcliffe PA, Day DM, et al. Silencing mutant SODI using RNAi protects against neurodegeneration and extends survival in an ALS model[J].Nat Med,2005,11:429-433.
  • 10Mathupala SP. Delivery of small-interfering RNA(SiRNA) to the brain[J]. Expert Opin Ther Pat,2009,19:137-140.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部